Abstract
Quantitative structure-activity relationship studies have been made on some calcium channel blockers (CCBs) that include the most widely studied class of 1,4-dihydropyridines and two new classes of CCBs, namely benzazepinone analogs and quinolizidinyl derivatives. In the case of 1,4-dihydropyridines some simple correlations have been found as compared to those reported in several earlier studies and in the other two classes it could be shown that the electronic parameters and the bulk of the molecules may be important for the activity of the compounds.
Letters in Drug Design & Discovery
Title: QSAR Studies on some Calcium Channel Blockers
Volume: 5 Issue: 5
Author(s): Mallari A. Naik, V. S.A. Kumar Satuluri and S. P. Gupta
Affiliation:
Abstract: Quantitative structure-activity relationship studies have been made on some calcium channel blockers (CCBs) that include the most widely studied class of 1,4-dihydropyridines and two new classes of CCBs, namely benzazepinone analogs and quinolizidinyl derivatives. In the case of 1,4-dihydropyridines some simple correlations have been found as compared to those reported in several earlier studies and in the other two classes it could be shown that the electronic parameters and the bulk of the molecules may be important for the activity of the compounds.
Export Options
About this article
Cite this article as:
Naik A. Mallari, Kumar Satuluri S.A. V. and Gupta P. S., QSAR Studies on some Calcium Channel Blockers, Letters in Drug Design & Discovery 2008; 5 (5) . https://dx.doi.org/10.2174/157018008784912090
DOI https://dx.doi.org/10.2174/157018008784912090 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antiepileptic Treatment Strategy in Vascular Malformations
Current Pharmaceutical Design Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders
Current Topics in Medicinal Chemistry Safety of Cabergoline in the Management of Pituitary Prolactin-Induced Symptoms with Patients Treated with Atypical Neuroleptics
Current Drug Safety Is a "Mitochondrial Psychiatry" in the Future? A Review
Current Psychiatry Reviews Sugar Sulfamates for Seizure Control: Discovery and Development of Topiramate, a Structurally Unique Antiepileptic Drug
Current Topics in Medicinal Chemistry <i>Thespesia populnea</i>: An Ethnomedicinal, Phytochemical and Pharmacological Review
The Natural Products Journal Synthesis, Neurotoxicity and Anticonvulsant Study of Some Benzothiazole Analogs
Letters in Drug Design & Discovery Pramipexole Tachyphylaxis and its Management in Bipolar Depression
Letters in Drug Design & Discovery GABA Puts a Stop to Pain
Current Drug Targets - CNS & Neurological Disorders Functional Food with Some Health Benefits, So Called Superfood: A Review
Current Nutrition & Food Science Diabetes, Cognitive Function, and the Blood-Brain Barrier
Current Pharmaceutical Design The Relevance of JAK2 in the Regulation of Cellular Transport
Current Medicinal Chemistry Seizures and Sodium Hydrogen Exchangers: Potential of Sodium Hydrogen Exchanger Inhibitors as Novel Anticonvulsants
CNS & Neurological Disorders - Drug Targets Understanding the Molecular Mechanisms of Betel miRNAs on Human Health
MicroRNA Combinatorics, Big Data, Neural Network & AI for Medicinal Chemistry & Drug Administration
Letters in Drug Design & Discovery Biomarkers of Alzheimer’s Disease: An Overview of the Recent Inventions
Recent Patents on Biomarkers [General Articles] Cannabinoids: Mechanisms and Therapeutic Applications in the CNS
Current Medicinal Chemistry Anticonvulsant, Anxiolytic and Antidepressant Properties of the β-caryophyllene in Swiss Mice: Involvement of Benzodiazepine-GABAAergic, Serotonergic and Nitrergic Systems
Current Molecular Pharmacology Neuroimaging of Consciousness and Sleep Spindles
Recent Patents on Medical Imaging Does Phosphodiesterase 11A (PDE11A) Hold Promise as a Future Therapeutic Target?
Current Pharmaceutical Design